Immunogenomic responder phenotype from a phase I trial of Anti-LAG3 or Anti-CD137 alone and in combination with Anti-PD-1 in patients with recurrent GBM Meeting Abstract
| Authors: | Jackson, C.; Choi, J.; Zhang, J.; Piotrowski, A.; Walbert, T.; Desai, A.; Ahluwalia, M.; Nabors, B.; Ye, X.; Desideri, S.; Fisher, J.; Wen, P.; Grossman, S.; Smith, K.; Pardoll, D.; Lim, M. |
| Abstract Title: | Immunogenomic responder phenotype from a phase I trial of Anti-LAG3 or Anti-CD137 alone and in combination with Anti-PD-1 in patients with recurrent GBM |
| Meeting Title: | 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 21 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2019 Nov 22-24 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-11-01 |
| Start Page: | iv122 |
| Language: | English |
| ACCESSION: | WOS:000509478702175 |
| PROVIDER: | wos |
| PMCID: | PMC6847812 |
| DOI: | 10.1093/neuonc/noz175.511 |
| Notes: | Meeting Abstract: IMMU-18 -- Source: Wos |
